Confronti finanziari Shield Therapeutics plc

Azioni

Tempo differito London S.E. Altri mercati azionari 09:33:52 22/01/2026			Variaz. 5gg	Var. 1 gen.
10,49 ^GBX	-1,96%		-8,09%	+9,64%

21/01	Shield Therapeutics raggiunge la positività del flusso di cassa grazie alla crescita dei ricavi	AN
21/01	Shield Therapeutics prevede di raggiungere l'utile operativo nel 2026	RE

Settore:

Regione:

Asse X:

Principali concorrenti

Aggiungi a un elenco 0 selezionato Solo clienti o iscritti possono usare questa funzione Accedi Registrati	Fatturato (Y-1)	Margine netto (Y-1)	Margine EBIT (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
SHIELD THERAPEUTICS PLC	30,33 Mln	-84,47%	-71,08%	-	-	-0.92x
REGENERON PHARMACEUTICALS, INC.	14,2 Mrd	31,07%	36,7%	19,23%	15,02%	-1.11x
SAMSUNG BIOLOGICS CO.,LTD.	3,08 Mrd	23,82%	29,03%	10,45%	6,49%	0.1x
CSL LIMITED	15,56 Mrd	19,3%	28,72%	16,36%	7,75%	1.74x
UCB	6,37 Mrd	17,31%	13,59%	11,21%	6,48%	0.99x
BIOGEN INC.	9,68 Mrd	16,87%	31,16%	10,36%	5,95%	1.06x
INCYTE CORPORATION	4,24 Mrd	0,77%	9,76%	5,27%	3,72%	-4.29x
INNOVENT BIOLOGICS, INC.	1,29 Mrd	-1%	-8,02%	-0,74%	-0,45%	-11.4x
ALTEOGEN INC.	69,63 Mln	59,01%	24,7%	28,77%	18,72%	-6.16x
MODERNA, INC.	3,24 Mrd	-110,04%	-121,91%	-28,77%	-21,87%	1.87x
BRIDGEBIO PHARMA, INC.	222 Mln	-241,44%	-267,22%	35,11%	-73,11%	-1.77x
INTRA-CELLULAR THERAPIES, INC.	681 Mln	-10,97%	-17,14%	-8,58%	-7,13%	8.63x
SWEDISH ORPHAN BIOVITRUM AB	2,35 Mrd	14,93%	22,42%	10,9%	5,41%	1.59x
AVIDITY BIOSCIENCES, INC.	10,9 Mln	-2.957,71%	-3.477,43%	-33,47%	-	3.99x
BIOMARIN PHARMACEUTICAL INC.	2,85 Mrd	14,96%	16,97%	8,05%	6,17%	-0.93x
AXSOME THERAPEUTICS, INC.	386 Mln	-74,47%	-72,74%	-231,63%	-49,66%	0.49x
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	308 Mln	4,73%	4,18%	0,85%	-	-5.29x
3SBIO INC.	1,25 Mrd	22,95%	28,06%	14,19%	8,74%	0.28x
KRYSTAL BIOTECH, INC.	291 Mln	30,69%	22,61%	10,34%	-	-8.45x
GRIFOLS, S.A.	7,47 Mrd	2,18%	18,81%	2,79%	0,74%	5.16x
Media	3,68 Mrd	-161,08%	-187,44%	-6,28%	-4,19%	-0,72x
Media ponderata per Capi.	6,84 Mrd	-68,76%	-80,14%	4,74%	2,2%	-0,36x